A Novel Homozygous Stop Mutation in IL23R Causes Mendelian Susceptibility to Mycobacterial Disease.
Male
Adult
Humans
Child
Middle Aged
Interleukin-17
/ genetics
Nuclear Receptor Subfamily 1, Group F, Member 3
/ genetics
Mycobacterium Infections
/ etiology
Mycobacterium Infections, Nontuberculous
/ genetics
Mutation
/ genetics
Interleukin-23
Genetic Predisposition to Disease
Receptors, Interleukin
/ genetics
IFN-γ
IL23R
inborn errors of immunity
mendelian susceptibility to mycobacterial disease
non-tuberculous mycobacteria
th17
Journal
Journal of clinical immunology
ISSN: 1573-2592
Titre abrégé: J Clin Immunol
Pays: Netherlands
ID NLM: 8102137
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
received:
28
03
2022
accepted:
27
06
2022
pubmed:
14
7
2022
medline:
30
11
2022
entrez:
13
7
2022
Statut:
ppublish
Résumé
Mendelian susceptibility to mycobacterial disease (MSMD) is caused by inborn errors of IFN-γ immunity. The most frequent genetic defects are found in IL12 or a subunit of its receptor. IL23R deficiency in MSMD has only been reported once, in two pediatric patients from the same kindred with isolated disseminated Bacille Calmette-Guérin disease. We evaluated the impact of a homozygous stop mutation in IL23R (R381X), identified by whole exome sequencing, in an adult patient with disseminated non-tuberculous mycobacterial disease. We performed functional validation of the R381X mutation by evaluating IL23R expression and IL-23 signaling (STAT3 phosphorylation, IFN-γ production) in primary cells (PBMCs, EBV-B cells) and cell lines (HeLa) with or without back-complementation of wild-type IL23R. We report on a 48-year-old male with disseminated non-tuberculous mycobacterial disease. We identified and characterized a homozygous loss-of-function stop mutation underlying IL23R deficiency, resulting in near absent expression of membrane bound IL23R. IL23R deficiency was characterized by impaired IL-23-mediated IFN-γ secretion in CD4 We demonstrate that impaired IL-23 immunity caused by a homozygous R381X mutation in IL23R underlies MSMD, corroborating earlier findings with a homozygous p.C115Y IL23R mutation. Our report further supports a model of redundant contribution of IL-23- to IL-17-mediated anti-fungal immunity.1.
Identifiants
pubmed: 35829840
doi: 10.1007/s10875-022-01320-7
pii: 10.1007/s10875-022-01320-7
pmc: PMC9700586
doi:
Substances chimiques
Interleukin-17
0
Nuclear Receptor Subfamily 1, Group F, Member 3
0
Interleukin-23
0
IL23R protein, human
0
Receptors, Interleukin
0
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1638-1652Informations de copyright
© 2022. The Author(s).
Références
J Immunol. 2011 Nov 15;187(10):5402-7
pubmed: 22003199
Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9560-5
pubmed: 21606346
Nat Rev Gastroenterol Hepatol. 2019 Mar;16(3):185-196
pubmed: 30478416
Proc Natl Acad Sci U S A. 2021 Apr 13;118(15):
pubmed: 33876776
Clin Vaccine Immunol. 2012 Aug;19(8):1188-92
pubmed: 22695161
Ann Clin Microbiol Antimicrob. 2022 Mar 1;21(1):8
pubmed: 35232430
Lancet. 1995 Aug 26;346(8974):581
pubmed: 7658805
J Immunol. 2006 Dec 15;177(12):8684-92
pubmed: 17142769
Hum Genet. 2020 Jun;139(6-7):1001-1009
pubmed: 32055999
Sci Immunol. 2018 Dec 21;3(30):
pubmed: 30578351
Cell. 2020 Dec 23;183(7):1826-1847.e31
pubmed: 33296702
J Biol Chem. 2016 Apr 15;291(16):8673-85
pubmed: 26887945
Nat Immunol. 2009 Mar;10(3):314-24
pubmed: 19182808
Genes Immun. 2008 Oct;9(7):631-9
pubmed: 18754016
Immunol Cell Biol. 2019 Apr;97(4):360-367
pubmed: 30264912
J Exp Med. 2015 Jun 1;212(6):855-64
pubmed: 25941256
Bioinformatics. 2018 Dec 15;34(24):4307-4309
pubmed: 30535305
Hum Genet. 2020 Jun;139(6-7):993-1000
pubmed: 32025907